Andrew Bloom
Primary Podiatric Medicine · Englewood, NJNPI 1750919957
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,365 of the $14,368 with a category attached, or 86.1%. 33 manufacturers reported payments, led by Stryker at 43.7% of the total. 2025 is the largest year on record at $6,206, 2.2 times the $2,764 reported in 2023. Among primary podiatric medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $61.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6K
- Integra Lifesciences Corporation$2K
- Royal Biologics, Inc.$1K
- Kerecis Limited$706
- Smith+Nephew$654
- Treace Medical Concepts, Inc.$455
- plus $3K from 27 others
What the payments were for
- Consulting fees$1,2008%
- Travel & lodging$7845%
- Food & beverage$12,36586%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 73 | $6,282 |
| Integra Lifesciences Corporation | 59 | $2,417 |
| Royal Biologics, Inc. | 2 | $1,200 |
| Kerecis Limited | 5 | $706 |
| Smith+Nephew | 14 | $654 |
| Treace Medical Concepts, Inc. | 9 | $455 |
| Tactile Systems Technology Inc | 7 | $290 |
| AbbVie | 7 | $221 |
| Seapearl East, Inc | 4 | $210 |
| Paratek Pharmaceuticals, Inc. | 6 | $209 |
| Convatec Inc. | 2 | $200 |
| Paragon 28, Inc. | 3 | $190 |
| Amgen | 4 | $167 |
| Extremity Medical | 2 | $147 |
| Biocomposites Inc | 1 | $143 |
| Guard Medical Inc. | 3 | $142 |
| Medtronic | 1 | $139 |
| Musculoskeletal Transplant Foundation Inc. | 6 | $97 |
| Lemaitre Vascular, Inc. | 2 | $89 |
| Orthofix Medical, Inc. | 2 | $54 |
| Curonix LLC | 2 | $50 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Averitas Pharma Inc. | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 2 | $33 |
| Hydrofera LLC | 1 | $32 |
| Cumberland Pharmaceuticals, Inc. | 2 | $29 |
| Dynasplint Systems Inc. | 2 | $28 |
| Next Science LLC | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
| Globus Medical | 1 | $17 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$4,434
- INTEGRA DERMAL REGENERATION TEMPLATE$1,439
- PRIMATRIX$1,439
- Kerecis SurgiClose$1,394
- CITREFIX$1,346
- Fibrinet$1,200
- Kerecis Omega3 SurgiClose$798
- PROstep$784
- INFINITY ADAPTIS$551
- INFINITY$371
- Kerecis GraftGuide$349
- PROSTEP MICA$342
- SALVATION$318
- Actishield$308
- GRAFIX PL$271
- INBONE$269
- Kerecis Omega3 GraftGuide$266
- Kerecis Omega3 Marigen$266
- VALOR$205
- VARIAX$169
How this compares
$14,368 in reported general payments places this provider in the 95th percentile of 45 primary podiatric medicine providers in New Jersey.
See all primary podiatric medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 23 | $7,217 |
| Gentamicin Sulfate | 37 | $1,355 |
| Gabapentin | 14 | $304 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $302 |
| Doxycycline Hyclate | 20 | $207 |
| Mupirocin | 16 | $197 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $177 |
| Meloxicam | 28 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $654 | $7,21723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 45 primary podiatric medicine providers in New Jersey.
Other primary podiatric medicine in Englewood
- Paul KleinWayne$6K
- Jessica AddeoHowell$5K
- Alicia LaiLinwood$5K
- Adenike SonaikeFair Lawn$5K
- Harvey KarpoWoodbury$5K
- Melissa ShinderMount Laurel$3K
- Richard MunozDover$3K
- Stephanie ExleyWoodbury$2K
- Richard FilipekGarfield$2K
- Robert TyrrellCherry Hill$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.